OS Therapies Incorporated
OSTX
$1.86
$0.031.64%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.63M | 11.47M | 12.35M | 11.25M | 9.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.61M | 33.87M | 28.71M | 19.68M | 15.24M |
| Operating Income | -37.61M | -33.87M | -28.71M | -19.68M | -15.24M |
| Income Before Tax | -39.37M | -35.27M | -28.75M | -18.28M | -14.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.37 | -35.27 | -28.75 | -18.28 | -14.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.37M | -35.27M | -28.75M | -18.28M | -14.28M |
| EBIT | -37.61M | -33.87M | -28.71M | -19.68M | -15.24M |
| EBITDA | -37.11M | -33.39M | -28.34M | -19.44M | -15.13M |
| EPS Basic | -1.07 | -1.05 | -0.96 | -59.76 | -59.72 |
| Normalized Basic EPS | -0.67 | -0.66 | -0.60 | -37.35 | -37.33 |
| EPS Diluted | -1.07 | -1.05 | -0.96 | -59.76 | -59.72 |
| Normalized Diluted EPS | -0.67 | -0.66 | -0.60 | -37.35 | -37.33 |
| Average Basic Shares Outstanding | 149.38M | 130.59M | 113.16M | 78.37M | 62.31M |
| Average Diluted Shares Outstanding | 149.38M | 130.59M | 113.16M | 78.37M | 62.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |